4The Non-Hodgkin' s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin' s lymphoma. Blood, 1997,89:3909-3918.
5Coiffier B. Diffuse large cell lymphoma. Curr Opin Oncol,2001,13:325- 334.
6Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer, 1998,83:806-812.
7Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 2004,103 : 275-282.
8Muffs J, Meijer C, Vos W, et al. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol, 2006,208 :714-723.
9Berglund M, Thtmberg U, Amini RM, et al. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mod Pathol, 2005 ,18 :1113-1120 .
10Kerckaert JP, Deweindt C, Tilly H, et al. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 transloeafions in human lymphomas. Nat Genet, 1993,5: 66-70.
